These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25552402)

  • 1. The effect of food on the high clearance drug asenapine after sublingual administration to healthy male volunteers.
    Dogterom P; de Greef R; Peeters PA
    Eur J Clin Pharmacol; 2015 Jan; 71(1):65-74. PubMed ID: 25552402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate reduces the glucuronidation of asenapine without affecting asenapine plasma concentrations.
    Gerrits MG; de Greef R; Dogterom P; Peeters PA
    J Clin Pharmacol; 2012 May; 52(5):757-65. PubMed ID: 21628604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjects.
    Gerrits M; de Greef R; Peeters P
    Biopharm Drug Dispos; 2010 Jul; 31(5-6):351-7. PubMed ID: 20549835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asenapine pharmacokinetics in hepatic and renal impairment.
    Peeters P; Bockbrader H; Spaans E; Dogterom P; Lasseter K; Marbury T; Gibson GL; de Greef R
    Clin Pharmacokinet; 2011 Jul; 50(7):471-81. PubMed ID: 21651314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers.
    Rioux N; Kim A; Nix D; Bowser T; Warmuth M; Smith PG; Schindler J
    Cancer Chemother Pharmacol; 2019 Jan; 83(1):91-96. PubMed ID: 30368584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
    Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
    Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asenapine pharmacokinetics and tolerability in a pediatric population.
    Dogterom P; Riesenberg R; de Greef R; Dennie J; Johnson M; Pilla Reddy V; Miltenburg AM; Findling RL; Jakate A; Carrothers TJ; Troyer MD
    Drug Des Devel Ther; 2018; 12():2677-2693. PubMed ID: 30214156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food Effect Study to Assess the Impact on Edaravone Pharmacokinetic Profiles in Healthy Participants.
    Shimizu H; Nishimura Y; Shiide Y; Akimoto M; Matsuda H; Kato Y; Hirai M
    Clin Ther; 2022 Dec; 44(12):1552-1565. PubMed ID: 36376130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070).
    Suzuki K; Castelli M; Komaroff M; Starling B; Terahara T; Citrome L
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):286-294. PubMed ID: 33734167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-dose, randomized, double-blind, placebo-controlled trial of sublingual asenapine for acute agitation.
    Pratts M; Citrome L; Grant W; Leso L; Opler LA
    Acta Psychiatr Scand; 2014 Jul; 130(1):61-8. PubMed ID: 24606117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age.
    Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
    Clin Ther; 2016 Jan; 38(1):39-52. PubMed ID: 26581327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Food on the Bioavailability of Omadacycline in Healthy Participants.
    Tzanis E; Manley A; Villano S; Tanaka SK; Bai S; Loh E
    J Clin Pharmacol; 2017 Mar; 57(3):321-327. PubMed ID: 27539539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
    Crockett J; Critchley D; Tayo B; Berwaerts J; Morrison G
    Epilepsia; 2020 Feb; 61(2):267-277. PubMed ID: 32012251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
    Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
    Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.
    Lincoln J; Stewart ME; Preskorn SH
    J Psychiatr Pract; 2010 Mar; 16(2):103-14. PubMed ID: 20511734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
    Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.
    Fagiolini A; Forgione RN; Morana B; Maccari M; Goracci A; Bossini L; Pellegrini F; Cuomo A; Casamassima F
    Expert Opin Pharmacother; 2013 Mar; 14(4):489-504. PubMed ID: 23356509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects.
    Lin TY; Yang MH; Chang FY
    Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
    Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
    BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.